Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -20757.65% is 3012% below its 5-year average of -667.12%, around the middle of its 5-year range (-52886.67%–49.45%).
19.19% below its 12-month average of -17416.20%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -2335.57%.
OPERATING MARGIN
-20757.65%
OPERATING MARGIN AVG TTM
-17416.20%
OPERATING MARGIN AVG 3Y
-3736.70%
OPERATING MARGIN AVG 5Y
-667.12%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-19.19%
CURRENT VS 3Y AVG
-455.51%
CURRENT VS 5Y AVG
-3011.55%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 748 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
HCW Biologics Inc.
Market Cap
$556226.00
Operating Margin
-20757.65%
TTM Avg
-17416.20%
3Y Avg
-3736.70%
5Y Avg
-667.12%
Market Cap
$680476.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$388862.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-952.12%
5Y Avg
-1206.12%
Market Cap
$809925.00
Operating Margin
N/A
TTM Avg
-1.14%
3Y Avg
-4.66%
5Y Avg
-4.48%
Market Cap
$822494.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-935.37%
5Y Avg
-623.58%
Market Cap
$848489.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-24.80%
Market Cap
$851241.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$880215.00
Operating Margin
-14.71%
TTM Avg
-14.51%
3Y Avg
-62.12%
5Y Avg
-354.09%
Market Cap
$888014.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HCW Biologics Inc. (HCWB) | $556226.00 | -20757.65% | -17416.20% | -3736.70% | -667.12% |
| CDT Equity Inc. (CDT)vs › | $680476.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Niki BioSolutions, Inc. (NIKI)vs › | $388862.00 | 0.00% | 0.00% | -952.12% | -1206.12% |
| Ridgetech, Inc. (RDGT)vs › | $809925.00 | N/A | -1.14% | -4.66% | -4.48% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $822494.00 | 0.00% | 0.00% | -935.37% | -623.58% |
| Decoy Therapeutics Inc. (DCOY)vs › | $848489.00 | 0.00% | 0.00% | 0.00% | -24.80% |
| Bone Biologics Corporation (BBLG)vs › | $851241.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Sunshine Biopharma, Inc. (SBFM)vs › | $880215.00 | -14.71% | -14.51% | -62.12% | -354.09% |
| GlucoTrack, Inc. (GCTK)vs › | $888014.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Silexion Therapeutics Ltd. (SLXN)vs › | $109400.00 | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
20.0%
Operating Margin
-20757.7%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -2335.57% |
| 2026-03-31 | 49.45% |
| 2025-12-31 | -10912.29% |
| 2025-09-30 | -20995.92% |
| 2025-06-30 | -52886.67% |
| 2025-03-31 | -38811.49% |
| 2024-12-31 | -800.34% |
| 2024-09-30 | -865.39% |
| 2024-06-30 | -2445.81% |
| 2024-03-31 | -665.09% |
| 2023-12-31 | -813.31% |
| 2023-09-30 | -595.23% |
| 2023-06-30 | -724.22% |
| 2023-03-31 | -12798.92% |
| 2022-12-31 | -422.45% |
| 2022-09-30 | -222.20% |
| 2022-06-30 | -773.36% |
| 2022-03-31 | -60.33% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 50.27% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
